| PET/CT and renal pathology: a blind spot for radiologists? Part 1, primary pathology. | |
| | |
MedLine Citation:
|
PMID: 22826417 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: PET/CT with (18)F-FDG shows metabolically active disease and is widely used for the diagnosis and follow-up of patients with cancer. Nonmetabolically active renal pathology may be missed without close attention to the CT portion of the study, whereas metabolically active pathology may be missed on PET because of physiologic tracer excretion in the kidneys. This article illustrates primary lesions of the kidney on FDG PET/CT with emphasis on key anatomic features and the appearance of tracer uptake. CONCLUSION: Close attention to both the FDG PET and CT portions of the study is essential to interpret renal pathology correctly on FDG PET/CT examinations. |
| | |
Authors:
|
Katherine Zukotynski; Aaron Lewis; Kevin O'Regan; Heather Jacene; Christopher Sakellis; Katherine Krajewski; David Israel |
Related Documents
:
|
21409347 - Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18f] ... 21250907 - Prenatal diagnosis of kniest dysplasia with three-dimensional helical computed tomography. 21132797 - How to design (13)c para-hydrogen-induced polarization experiments for mri applications. 21521907 - Measurement of lung airways in three dimensions using hyperpolarized helium-3 mri. 20505307 - Middle fossa approach to a temporosphenoidal encephalocele -technical note-. 8749217 - Endoluminal ultrasound and low-field magnetic resonance imaging are superior to clinica... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: AJR. American journal of roentgenology Volume: 199 ISSN: 1546-3141 ISO Abbreviation: AJR Am J Roentgenol Publication Date: 2012 Aug |
Date Detail:
|
Created Date: 2012-07-24 Completed Date: 2012-10-24 Revised Date: 2013-05-20 |
Medline Journal Info:
|
Nlm Unique ID: 7708173 Medline TA: AJR Am J Roentgenol Country: United States |
Other Details:
|
Languages: eng Pagination: W163-7 Citation Subset: AIM; IM |
Affiliation:
|
Department of Imaging, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA 02115, USA. kzukotynski@partners.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Diagnosis, Differential Fluorodeoxyglucose F18 / diagnostic use Humans Kidney Neoplasms / pathology, radionuclide imaging* Positron-Emission Tomography and Computed Tomography* Radiopharmaceuticals / diagnostic use |
| Chemical | |
Reg. No./Substance:
|
0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Preoperative needle biopsy of sentinel lymph nodes using intradermal microbubbles and contrast-enhan...
Next Document: PET/CT and renal pathology: a blind spot for radiologists? Part 2--lymphoma, leukemia, and metastati...